November 1, 2019
Dr. Reddy’s Q2 & H1 FY20 Financial Results
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results…
Pharmaceuticals, Biotechnology and Life Sciences
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results…
Hemlibra is launched for hemophilia A with inhibitors in Taiwan on 1 November 2019 TOKYO–(BUSINESS WIRE)–#antibody—Chugai Pharmaceutical Co., Ltd. (TOKYO:…
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its…
Foresite Labs supports creative entrepreneurs working to solve our greatest unmet medical needs SAN FRANCISCO & BOSTON–(BUSINESS WIRE)–Foresite Labs, LLC,…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Checkmate Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused upon activation of innate immunity to treat cancer, today…
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that it will host a conference call and webcast to report its…
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the…
– Continued progress towards 2022 vision of four marketed gene and cell therapy products with robust development pipeline – –…
New analyses from filgotinib clinical development program reinforce the investigational medicine’s consistent efficacy and safety profile in the treatment of…